Simulations Plus Inc SLP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
-
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
-
Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?
-
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
-
SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders
-
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation
-
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—CRNX, SLP, NCSM, and PASG
-
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PULM, SLP, OLN, and HUN
Trading Information
- Previous Close Price
- $18.50
- Day Range
- $18.49–18.50
- 52-Week Range
- $11.09–21.01
- Bid/Ask
- $18.47 / $18.60
- Shares Outstanding
- 20.22M
- Market Cap
- $374.16M
- Volume/Avg
- 625,309 / 296,965
Key Statistics
- Price/Earnings (Normalized)
- 29.51
- Price/Sales
- 4.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 213
- Website
- https://www.simulations-plus.com
Valuation
|
Metric
|
SLP
|
|---|---|
Price/Earnings (Normalized) | 29.51 |
Price/Book Value | 2.69 |
Price/Sales | 4.56 |
Price/Cash Flow | 15.91 |
Price/Earnings
SLP
Financial Strength
|
Metric
|
SLP
|
|---|---|
Quick Ratio | 4.95 |
Current Ratio | 5.54 |
Interest Coverage | — |
Quick Ratio
SLP
Profitability
|
Metric
|
SLP
|
|---|---|
Return on Assets (Normalized) | 12.58% |
Return on Equity (Normalized) | 13.65% |
Return on Invested Capital (Normalized) | 13.03% |
Return on Assets
SLP
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|S!NJ?#y | LOCK|%sN | $46B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|c$ | $15B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|Hg@% | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|mn#hW | $12B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|@>!D | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|m>P> | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|>&Ht | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|vy&wQ | $7B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|S!nXq | $7B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|&mq | $5B |
United States